This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
moving-average-crossover: Archive
SOPHiA GENETICS (SOPH) Moves 7.0% Higher: Will This Strength Last?
by Zacks Equity Research
SOPHiA GENETICS (SOPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
SOPHNegative Net Change SDGRPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Generac Holdings (GNRC) Moves 18.3% Higher: Will This Strength Last?
by Zacks Equity Research
Generac Holdings (GNRC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
GNRCPositive Net Change GTESPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Novavax (NVAX) Soars 7.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
NVAXPositive Net Change NEONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
ImmunityBio (IBRX) Moves 7.0% Higher: Will This Strength Last?
by Zacks Equity Research
ImmunityBio (IBRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
IBRXPositive Net Change PTCTPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Arcutis Biotherapeutics (ARQT) Moves 11.2% Higher: Will This Strength Last?
by Zacks Equity Research
Arcutis Biotherapeutics (ARQT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ARQTPositive Net Change TGTXPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Abercrombie & Fitch (ANF) Just Overtook the 20-Day Moving Average
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
ANFNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
Strength Seen in Axon (AXON): Can Its 6.0% Jump Turn into More Strength?
by Zacks Equity Research
Axon (AXON) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
AXONPositive Net Change CAEPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Amneal (AMRX) Surges 8.6%: Is This an Indication of Further Gains?
by Zacks Equity Research
Amneal (AMRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
AMRXNegative Net Change IONSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
GrafTech (EAF) Soars 13.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
GrafTech (EAF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
EAFPositive Net Change KALUPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Beta Bionics, Inc. (BBNX) Surges 15.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Beta Bionics, Inc. (BBNX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
BBNXPositive Net Change CVRXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today